| 000 | 01148 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513082442.0 | ||
| 264 | 0 | _c19930629 | |
| 008 | 199306s 0 0 eng d | ||
| 022 | _a0934-9723 | ||
| 024 | 7 |
_a10.1007/BF01967595 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDan, M | |
| 245 | 0 | 0 |
_aMarked decrease in susceptibility of Shigella to ampicillin and cotrimoxazole in Israel. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cFeb 1993 |
||
| 300 |
_a143-4 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAmpicillin _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aIsrael |
| 650 | 0 | 4 |
_aShigella _xdrug effects |
| 650 | 0 | 4 |
_aTrimethoprim, Sulfamethoxazole Drug Combination _xpharmacology |
| 773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 12 _gno. 2 _gp. 143-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01967595 _zAvailable from publisher's website |
| 999 |
_c8499751 _d8499751 |
||